Get started
Author

Ingrid Poláková

Observed names: I Polakova, I Poláková, I. Poláková, INGRID POLAKOVA, Ingrid Polakova, Polakova, Ingrid, Poláková, Ingrid
Institution: Charles University
ORCID: 0000-0003-1315-0924
Observed ORCID: 0000-0003-1315-0924
OpenAlex ID: A5015750086
CD80 Expression on Tumor Cells Alters Tumor Microenvironment and Efficacy of Cancer Immunotherapy by CTLA-4 Blockade
2021 · Julie Vackova, Ingrid Polakova, et al. · Cancers · 34
PDF
Antitumor DNA vaccination against the Sox2 transcription factor
2014 · INGRID POLAKOVA, MARTINA DUSKOVA, et al. · International Journal of Oncology · 27
PDF
Vaccination with human papillomavirus type 16-derived peptides using a tattoo device
2009 · Dana Pokorná, Ingrid Poláková, et al. · Vaccine · 25
Establishment and characterization of a mouse tumor cell line with irreversible downregulation of MHC class I molecules
2019 · Karolina Lhotakova, Adrianna Grzelak, et al. · Oncology Reports · 23
PDF
Enhancement of DNA Vaccine Potency Against Legumain
2014 · Michal Smahel, Martina Duskova, et al. · Journal of Immunotherapy · 21
The effect of helper epitopes and cellular localization of an antigen on the outcome of gene gun DNA immunization
2014 · M Smahel, I Polakova, et al. · Gene Therapy · 17
Mutation in the immunodominant epitope of the HPV16 E7 oncoprotein as a mechanism of tumor escape
2007 · Michal Smahel, Pavla Tejklova, et al. · Cancer Immunology Immunotherapy · 15
DNA vaccine against human papillomavirus type 16: Modifications of the E6 oncogene
2009 · Ingrid Poláková, Dana Pokorná, et al. · Vaccine · 14
Systemic Administration of CpG Oligodeoxynucleotide and Levamisole as Adjuvants for Gene-Gun-Delivered Antitumor DNA Vaccines
2011 · Michal Šmahel, Ingrid Poláková, et al. · Clinical and Developmental Immunology · 13
PDF
Enhancement of T cell-mediated and humoral immunity of β-glucuronidase-based DNA vaccines against HPV16 E7 oncoprotein
2008 · Michal Smahel, Ingrid Poláková, et al. · International Journal of Oncology · 13
PDF
Distinct Responsiveness of Tumor-Associated Macrophages to Immunotherapy of Tumors with Different Mechanisms of Major Histocompatibility Complex Class I Downregulation
2021 · Adrianna Piatakova, Ingrid Polakova, et al. · Cancers · 11
PDF
Experimental Combined Immunotherapy of Tumours with Major Histocompatibility Complex Class I Downregulation
2018 · Adrianna Grzelak, Ingrid Polakova, et al. · International Journal of Molecular Sciences · 10
PDF
Implementation of Mass Cytometry for Immunoprofiling of Patients with Solid Tumors
2019 · Ingrid Poláková, Ondřej Pelák, et al. · Journal of Immunology Research · 7
Enhancement of T Cell-Mediated and Humoral Immunity of Beta-Glucuronidase-Based DNA Vaccines against HPV-16 E7 Oncoprotein
2008 · Michal Šmahel, Ingrid Poláková, et al. · Central European Journal of Public Health · 7
Combined Cancer Immunotherapy Against Aurora Kinase A
2016 · Iva Kaštánková, Ingrid Poláková, et al. · Journal of Immunotherapy · 6
Expression of a recombinant Human papillomavirus 16 E6GT oncoprotein fused to N- and C-termini of Potato virus X coat protein in Nicotiana benthamiana
2012 · Noemi Cerovska, Tomas Moravec, et al. · Plant Cell Tissue and Organ Culture (PCTOC) · 6
PDF
Heterogeneous Response of Tumor Cell Lines to Inhibition of Aspartate β-hydroxylase
2024 · Madiha Kanwal, Ingrid Polakova, et al. · Journal of Cancer · 4
Evaluation of IFN-γ Enzyme-linked Immunospot Assay (ELISPOT) as a First-line Test in the Diagnosis of Non-Immediate Hypersensitivity to Amoxicillin and Penicillin
2018 · Lenka Sedláčková, Miroslav Průcha, et al. · Prague Medical Report · 4
PDF
Developing molecular surveillance of SARS-CoV-2 in the Czech Republic (2021–2022)
2025 · Timotej Šúri, Lucie Pfeiferová, et al. · Scientific Reports · 3
PDF
Abrogation of IFN-γ Signaling May not Worsen Sensitivity to PD-1/PD-L1 Blockade
2020 · Julie Vackova, Adrianna Piatakova, et al. · International Journal of Molecular Sciences · 2
PDF
Multiparametric analysis of the specific immune response against SARS-CoV-2
2024 · Lucie Vránová, Ingrid Poláková, et al. · Scandinavian Journal of Infectious Diseases · 1
415P Intratumoral MHC-I heterogeneity: Spatiotemporal insights into the immune microenvironment
2025 · B. Zucha, I. Poláková, et al. · Immuno-Oncology Technology
PDF
Inhibition of Aspartate β-Hydroxylase Enhances Anti-Tumor Immunity
2025 · Shweta Johari, Katerina Krausova, et al. · ImmunoTargets and Therapy
The role of aspartate beta-hydroxylase in tumors associated with human papillomaviruses
2025 · Kanwal, Madiha, Šmahelová, Jana, et al. · CU Research Publications Repository
PDF
The role of β-2-microglobulin in tumor development
2025 · Žucha, Barbora, Poláková, Ingrid, et al. · CU Research Publications Repository
Works count: 37
Citation count: 263
H-index: 11
I10-index: 12
Year
Topic
Type